Let's talk medical research

[Updated June 2019]

With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for and interested in a particular clinical trial. Traditional methods of recruitment are becoming less impactful, which is why it’s time to consider a new approach: precision recruitment.

For years, clinical trial patient recruitment has looked the same: identify eligibility criteria for a single trial, conduct traditional media outreach, screen patients for that trial, and hope for the best. Increasingly, however, sponsors have been turning to technology, getting more specific in their outreach and therefore becoming more successful in their recruiting not just for one trial, but ...

One of the most frustrating elements of medical research today is the speed — patients need new treatments now, but often, clinical trials are delayed or closed due to difficulty finding patients to take part. With clinical trial patient recruitment, sponsors can not only meet deadlines, but beat them, bringing new treatments to patients faster. Here, we break down the key reasons to set your ...

The clinical trial landscape is shifting — but is it enough? Antidote’s Founder, Pablo Graiver, was recently interviewed for the Relentless Health Value podcast to discuss this fundamental question.

The American Cancer Society Cancer Action Network (ACS CAN) recently published a whitepaper detailing different approaches to clinical trial matching, and providing examples of each. The paper notes that 66% of cancer patients find their clinical trials through their physician or a staff member working on the clinical trial, while just 6% found a trial through self-service matching services, and ...

You may have noticed that for the past several weeks, we’ve been sharing quite a few patient, researcher, and partner stories here at Antidote. That’s because we believe that accelerating medical research is more than clinical trial matching; patients also need to be educated on the importance of research and inspired to take part. And who better to do that than other patients?

It all started with a phone call. Sandy, in tears, called Ira, her husband of over 30 years. She told him that she couldn’t find the Pilates studio where she practiced for years. It was a trip she had taken from their apartment in New York City countless times. The following week, they made an appointment with a neurologist. Soon after, Sandy would be given a diagnosis of mild cognitive ...

With a long line of disappointments in failed clinical trials, the last few years have not been good ones for drug development in Alzheimer’s disease. TURNING POINT is a documentary, produced in conjunction with BrightFocus Foundation, that follows the journey of researchers and patients working together on a trial for a new Alzheimer’s drug. The drug solanezumab, investigated by Eli Lilly & ...

Cancer Treatment Centers of America (CTCA) is a five-hospital system with a national footprint. As a specialty provider in cancer care, the system sees 20,000 cancer patients annually, and consistently ranks in the top 3% of all hospitals in terms of patient satisfaction. In addition, the organization is one that has worked to harness the therapeutic benefits of patient storytelling through a ...